The market is driven by strong biomedical research funding, advanced laboratory infrastructure, and rising demand for precise cell isolation techniques in diagnostics and therapeutics. Growth is further supported by increasing adoption in cancer research, stem cell, and personalized medicine, alongside continuous technological innovations from key industry players.
Buoyancy activated cell sorting is a technique that separates cells based on their density in a fluid, enabling precision and label-free cell isolation. The U.S. buoyancy activated cell sorting (BACS) market is growing due to increasing demand for high-precision, label-free cell isolation in biomedical research and critical diagnostics. Strong government funding, expanding cancer and stem cell research, and rising adoption of advanced sorting technologies are key drivers. Additionally, the presence of leading biotech firms and continuous innovation in microfluidics and cell analysis platforms further accelerates market expansion.
The global buoyancy activated cell sorting (BACS) market size was estimated at USD 185 million in 2025 and is predicted to increase from USD 208.68 million in 2026 to approximately USD 616.97 million by 2035, expanding at a CAGR of 12.8% from 2026 to 2035.
| Parameter (NIH Data) | 2024 | 2025 |
| Total NIH funding | 48.0 billion | 48.5 billion |
| Total grant funding | 35.15 billion | 35.30 billion |
| Research project grant (RPG) applications | 55,418 | 62,592 |
| Success rate of grants | 18.5% | 13% |
| Average grant size | 620,265 | 675,426 |
The comparison shows that while overall NHI funding slightly increased in 2025, research activity showed a notable rise in applications. However, declining success rates indicate growing competition for funding. At the same time, the increase in average grant size highlights stronger financial support per project, fostering advanced biomedical research and accelerating demand for technologies like cell sorting.
The instruments segment dominated the market with a revenue share of 48% in 2025 due to high demand for advanced, high-throughput sorting systems in research and clinical labs. These instruments enable precision, automated, and scalable cell separations, making them essential for cancer research and cell therapy development. Their high cost and recurring upgrade further drive revenue dominance compared to consumables and services.
The density gradient- based sorting segment held a dominant the U.S. buoyancy activated cell sorting (BACS) market with a share of 42% in 2025 due to its cost-effectiveness, simplicity, and widespread adoption in laboratories. It enables efficient separation of cells without complex instruments, making it ideal for routine research and clinical workflows. High reliability, scalability, and compatibility with various sample types further strengthened its preferences over advanced but expensive sorting technologies.
The clinical diagnostics segment led the U.S. buoyancy activated cell sorting (BACS) market with a share of 34% in 2025 due to rising demand for accurate and early disease detection, especially in cancer and infectious diseases. Buoyancy-based cell sorting enables precise isolation of target cells, improving diagnostic accuracy. Increasing hospital adoption, growing patient volumes, and the shift towards personalized medicine further strengthened its dominance in clinical applications.
The academic & research institutes segment held a dominant the market with a share of 36% in 2025 due to strong government funding, extensive life science research activities, and early adoption of advanced cell sorting technologies. These institutes drive innovation in cancer biology and stem research, requiring precise cell isolation tools, thereby boosting demand for buoyancy-activated cell sorting systems.
Leading companies in the U.S. market include Akadeum Life Sciences, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, and Miltenyi Biotec. These companies lead through advanced cell isolation platforms such as microbubble-based buoyancy sorting, flow cytometry, and magnetic separation technologies, driving innovation in cell therapy, immunology, and cancer research with improved efficiency, scalability, and precision.
By Product Type
By Technology
By Application
By End User
